Life Science Investing Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
Life Science Investing Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea